DAVID YONTS: Open Payments
NPI 1609563212 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 64 payments from 12 companies in 2025. Trend: 2023 $106 · 2024 $654 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $322 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $172 |
| Corium, LLC | 8 | $92 |
| Alkermes, Inc. | 5 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Biogen, Inc. | 3 | $69 |
| ABBVIE INC. | 4 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: FANAPT, CAPLYTA, Azstarys, COBENFY, ZURZUVAE, VRAYLAR, Jornay PM, LYBALVI.
Industry payments across KY — which companies pay providers there.
